Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2112 of 6351
-
Two-Drug combo tested for tough thyroid cancer
Disease control OngoingThis randomized phase II trial studies the effects, good and bad, of using everolimus along with sorafenib tosylate versus sorafenib tosylate alone in treating patients with advanced radioactive iodine refractory thyroid cancer. Sorafenib tosylate and everolimus may stop the grow…
Phase 2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Lifesaving drug made available for rare fat disorder patients
Disease control OngoingBackground: \- Generalized lipodystrophy can cause high blood fat levels and resistance to insulin. This can lead to health problems including diabetes. Researchers have found that the drug metreleptin improves health in people with this disease. Objective: \- To test the safe…
Phase 3 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Can less radiation be safer without sacrificing cancer control?
Disease control CompletedIn patients with squamous cell carcinoma of the oral cavity, the oropharynx and larynx with \>= pT3 and or pN+ postoperative radio - or radiochemotherapy is the standard of care. Postoperative radiochemotherapy is indicated in patients with multiple lymph node metastasis, lymph n…
Phase 2 • Sponsor: University of Erlangen-Nürnberg Medical School • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Oxygen therapy shows promise for stubborn diabetic foot sores
Disease control CompletedThe purpose of this study is to evaluate the efficacy, safety and economical benefits of Cyclical Pressure Topical Wound Oxygen (TWO2) Therapy in the treatment of chronic diabetic foot ulcers. Subjects will wear a standardized off-loading device and use advanced moist wound thera…
Sponsor: AOTI Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New drug shows promise for Hard-to-Treat cancers with p53 gene
Disease control CompletedThis study evaluates the anti-tumor effects of ALRN-6924 in patients with advanced solid tumors or lymphomas with WT TP53.
Phase 1/2 • Sponsor: Aileron Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Silent after surgery: new study hunts for clues to mysterious speech loss in kids
Knowledge-focused Recruiting nowThe purpose of this study is to determine why up to 25% of the pediatric patients who have surgery for a tumor in the posterior fossa develops the Cerebellar Mutism Syndrome (CMS). Furthermore the purpose is to explore the clinical course and the best treatment of the syndrome.
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Breathing low oxygen may spark nerve repair after spinal injury
Knowledge-focused Recruiting nowAccumulating evidence suggests that repeatedly breathing low oxygen levels for brief periods (termed intermittent hypoxia) is a safe and effective treatment strategy to promote meaningful functional recovery in persons with chronic spinal cord injury (SCI). The goal of the study …
Sponsor: Spaulding Rehabilitation Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Can a special diet calm your gut? new study tests food as medicine for Crohn's and colitis
Disease control OngoingThe study is proposed as a 2-year single site, open-label clinical trial of enteral nutrition or the specific carbohydrate diet in patients with active CD or UC. Patients seeking care in the outpatient clinics of the Division of Gastroenterology at Massachusetts General Hospital …
Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Brain surgery infection fighter: vancomycin powder put to the test
Disease control CompletedThis study is a collaboration between New York Presbyterian (NYP)-Columbia and NYP-Cornell that seeks to evaluate the use of topical vancomycin and its reduction on surgical site infection (SSI) in neurosurgical procedures. Adult patients undergoing neurosurgery at either institu…
Phase 3 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Nurse support boosts TB treatment in south africa
Disease control OngoingThe researchers of this study are observing the treatment of multi-drug resistant Mycobacterium tuberculosis (MDR-TB) in South Africa. MDR-TB can not be treated with the usual TB drugs and needs to be treated with special drugs. The patients need to take these drugs for up to two…
Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Massive lung cancer study aims to match patients with targeted therapies
Knowledge-focused OngoingThis ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain ge…
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC
-
Massive brain injury study aims to unlock secrets of recovery
Knowledge-focused Recruiting nowBackground: While the intensive care of patients with life-threatening brain illnesses has advanced tremendously, a large number of therapies are still without proper scientific support. This can be partly explained by the fact that mechanisms of initial brain injury are still …
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New drug combo shows promise for tough breast cancer
Disease control CompletedThis study will evaluate the effectiveness and safety of the combination of two drugs, Veliparib and Lapatinib, given to participants with metastatic triple negative breast cancer that have undergone previous treatment. Veliparib is an investigational drug and has not been approv…
Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Scientists hunt for the most stubborn prostate cancer cells inside human tumors
Knowledge-focused OngoingProstate cancer is the most commonly diagnosed form of cancer in Canadian men. In 2006, greater than 250,000 men were diagnosed with prostate cancer in the United States and Canada with more than 32,000 men dying of their disease. Using the prognostic variables of T-category, the…
Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
New drug cocktail shows promise for tough bile duct cancer
Disease control CompletedThis study is to determine the Regorafenib Dose (RD) for the phase II trial of Regorafenib administered in combination with mGEMOX in patients with advanced biliary tract cancer.
Phase 1/2 • Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New targeted therapy shows promise for Tough-to-Treat leukemia
Disease control CompletedThis research study is studying a targeted therapy known as GO-203-2C as a possible treatment for with acute myeloid leukemia (AML) both alone and in combination with decitabine. GO-203-2c targets cancer cells, while leaving healthy cells unaffected.This is a Phase I/II clinical …
Phase 1/2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a 20-Week class rewire the hoarding brain?
Symptom relief CompletedThe purpose of this protocol is to investigate the effectiveness of a manualized, 20-week group cognitive rehabilitation (CR) and exposure therapy (ET) course for compulsive hoarding. The overarching aim is to understand whether this course will decrease the core symptoms of hoar…
Sponsor: University of Miami • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
Experimental cell shot aims to boost brain repair in kids with rare metabolic diseases
Disease control Recruiting nowThe primary objective of the study is to determine the safety and feasibility of intrathecal administration of DUOC-01 in patients who are undergoing standard treatment with umbilical cord blood transplant (UCBT) for inborn errors of metabolism and who have evidence of early demy…
Phase 1 • Sponsor: Joanne Kurtzberg, MD • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
Could a diet and exercise program help childhood leukemia survivors live healthier?
Disease control CompletedThe EQUAL study has been designed for adult survivors of childhood acute lymphoblastic leukemia (ALL) who are overweight or obese. The purpose of this study is to see if diet and exercise can help people lose weight and improve other health problems. This two year study will comp…
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New combo therapy aims to delay prostate cancer relapse in patients with limited spread
Disease control CompletedThere is an increasing number of reports describing the existence of a proportion of prostate cancer patients who present with a reduced number of metastases (\<5 lesions) at relapse. This oligometastatic status has also been recognized in other tumor types such as melanoma, soft…
Phase 2 • Sponsor: Institut Cancerologie de l'Ouest • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC